In a landmark decision that will reshape how we approach obesity treatment worldwide, the World Health Organization1 has released its first-ever clinical guidelines recommending GLP-1 therapies for adults living with obesity. This isn’t merely another drug approval or incremental policy update; it represents a transformation in how the world’s leading health authority understands and addresses a condition affecting over 1 billion people globally.
Similar Posts
Taking Racism out of the Kidney Disease Equation
proposed dropping the use of the racialized eGFR in favor of a race-neutral eGFR. As a result,…
How Do We Ensure Digital Mental Health Solutions Reach Underserved Youth?
Digital solutions have greatly expanded access to mental health support, though they’re not always reaching the…
Links – Healthcare Economist
When Interest Rates Go Low, Should Public Debt Go High? ROI for SDOH interventions. Consumption responses…
Age-Related Macular Degeneration: Putting a Hole in Our World
May 10, 2024 – When we’re young, we take our macula for granted. At the center…
Hodgepodge Sweet Corn Smash Burger
You’re going to fall in love with this amazing sweet corn smash burger! Two smash patties…
Why Choosing The Right Calorie Goal Is Important For Weight Loss
If you’re like many people on a weight loss journey, there’s a chance you’re cutting more…
